DOSSIER·REF / RETATRUTIDE·CAS 2381089-83-2
SECURE CHANNEL · LIVE
Retatrutide vial · in-vitro research reference material
VALIDATION · HPLC-CERTIFIED
≥99%
ANALYTICAL REFERENCE

Retatrutide

LAB VERIFIED · JANOSHIK COA
REF / PRICE · 10MG
€124.99PER UNIT
GRATIS VERZENDINGVolume-tarief boven €100 · 1-2d levering
CHOOSE VARIANT
VOLUME TIERS · BULK DISCOUNT
1× MORE FOR −5%
// Discount counts against the total of Peptiden & Orals in your cart.
COMPOUND PROFILE

Triple-agonist next-generation incretin research peptide (Phase III body-weight studies).

PubMed LiteratureRetatrutide · pharmacology & mechanism filter →
// RESEARCH DOSSIER ACCESS
Want to go deeper into the biochemistry? VIEW THE FULL RETATRUTIDE RESEARCH DOSSIER
LIVE ANALYSIS MONITOR
JANOSHIK · ≥99%

Independent HPLC / MS Analysis

Analytical certificate issued by Janoshik Analytical · Identity, purity and lot authenticity verified against retention-time and parent-ion mass references.

STATUS
100% COMPLETE
FEED
RP-HPLC · LIVE
PROBE
C18 · 220nm
RT
2.14 MIN
Open Analytical Certificate
Research Compliance

For In-Vitro Laboratory Research only. Not for human or animal consumption. This material is supplied as an analytical reference standard for laboratory research. It is not a medicine, food, cosmetic or medical device.

DOSSIER · TECHNICAL SPECIFICATION
CAS 2381089-83-2 · VALIDATION HPLC-CERTIFIED
CAS
2381089-83-2
FORMULA
C₂₂₁H₃₄₃N₄₇O₆₅
MOL. WEIGHT
4731.4 g/mol
PURITY
≥99%
FORM
Wit lyofiel poeder
SOLUBLE
Oplosbaar in bacteriostatisch water (BAC)
STABILITY
Stabiel 24 maanden @ -20°C, 30 dagen na reconstitutie @ 2-8°C
ANALYSIS
RP-HPLC · MS · NMR
VALIDATION
HPLC-CERTIFIED
SEQUENCE
Triple agonist (GLP-1 / GIP / Glucagon receptor)
IN-VITRO DOCUMENTATION
External references are objective, peer-reviewed sources. Primal Shop EU is not the author or endorser of third-party publications.
1
RELATED RESEARCH

Synergistic reference standards

Peptides routinely studied alongside this compound in published in-vitro protocols. Cross-link only — not a medical recommendation.